Public annual accounts

LOXYGENE financials

Name: LOXYGENE financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for LOXYGENE, with comparable measures and links to available source documents.

Company overview

Registry number

1002865182

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for LOXYGENE

2025 versus 2024

Operating line: €12,315
EBITDA: €9,819
Total assets: €57,475
Equity: €26,519

EBITDA margin +79.7% · Equity ratio +46.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€12,315	€9,819	€57,475	€26,519	-
202431 Dec 2024	€50,500	€48,501	€62,084	€26,378	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report